Man Zhao

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.

Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.

Journal: Advances in therapy

Published: May 08, 2025

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4.

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4.

Journal: Blood cancer journal

Published: April 02, 2025

Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study.

Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study.

Journal: Annals of hematology

Published: October 10, 2024

Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.

Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.

Journal: Annals of hematology

Published: September 23, 2024

Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study.

Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study.

Journal: Annals of hematology

Published: April 26, 2024

Force Prediction and Material Removal Mechanism Analysis of Milling SiCp/2009Al.

Force Prediction and Material Removal Mechanism Analysis of Milling SiCp/2009Al.

Journal: Micromachines

Published: September 16, 2022

A Ti-6Al-4V Milling Force Prediction Model Based on the Taylor Factor Model and Microstructure Evolution of the Milling Surface.

A Ti-6Al-4V Milling Force Prediction Model Based on the Taylor Factor Model and Microstructure Evolution of the Milling Surface.

Journal: Micromachines

Published: September 10, 2022

Efficient extraction of low-abundance peptides from digested proteins and simultaneous exclusion of large-sized proteins with novel hydrophilic magnetic zeolitic imidazolate frameworks.

Efficient extraction of low-abundance peptides from digested proteins and simultaneous exclusion of large-sized proteins with novel hydrophilic magnetic zeolitic imidazolate frameworks.

Journal: Talanta

Published: November 23, 2016

Fluorous modified magnetic mesoporous silica composites-incorporated fluorous solid-phase extraction for the specific enrichment of N-linked glycans with simultaneous exclusion of proteins.

Fluorous modified magnetic mesoporous silica composites-incorporated fluorous solid-phase extraction for the specific enrichment of N-linked glycans with simultaneous exclusion of proteins.

Journal: Talanta

Published: April 15, 2016

Designed synthesis of fluorous-functionalized magnetic mesoporous microspheres for specific enrichment of phosphopeptides with fluorous derivatization.

Designed synthesis of fluorous-functionalized magnetic mesoporous microspheres for specific enrichment of phosphopeptides with fluorous derivatization.

Journal: Proteomics

Published: August 12, 2015

Rational synthesis of novel recyclable Fe₃O₄@MOF nanocomposites for enzymatic digestion.

Rational synthesis of novel recyclable Fe₃O₄@MOF nanocomposites for enzymatic digestion.

Journal: Chemical communications (Cambridge, England)

Published: April 15, 2015

The design and synthesis of a hydrophilic core-shell-shell structured magnetic metal-organic framework as a novel immobilized metal ion affinity platform for phosphoproteome research.

The design and synthesis of a hydrophilic core-shell-shell structured magnetic metal-organic framework as a novel immobilized metal ion affinity platform for phosphoproteome research.

Journal: Chemical communications (Cambridge, England)

Published: May 03, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026